Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study

被引：0
|
作者：
Yoon Hee Park
Jong Mi Seong
Soyeon Cho
Hye Won Han
Jae Youn Kim
Sook Hee An
Hye Sun Gwak
机构：
[1] Ewha Womans University,Division of Life and Pharmaceutical Sciences, College of Pharmacy
[2] Asan Medical Center,Department of Pharmacy
[3] Wonkwang University,College of Pharmacy
来源：
Journal of Gastroenterology | 2019年 / 54卷
关键词：
Proton pump inhibitor; C; Diarrhea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1052 / 1060
页数：8
相关论文
共 50 条
  • [41] Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
    Barletta, Jeffrey F.
    Sclar, David A.
    CRITICAL CARE, 2014, 18 (06):
  • [42] Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
    Jeffrey F Barletta
    David A Sclar
    Critical Care, 18
  • [43] Association of Antibiotic and Proton Pump Inhibitor Usage in Patients with Hospital Acquired Clostridium difficile Infection: A Single Center Experience
    Ballecer, Eric
    Ali, Mohammad
    Patel, Zinal
    Shen, Mark
    Islam, Shahidul
    Vrabie, Raluca
    Grendell, James H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S635 - S635
  • [44] Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea
    Yearsley, K. A.
    Gilby, L. J. .
    Ramadas, A. V.
    Kubiak, E. M.
    Fone, D. L.
    Allison, M. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (04) : 613 - 619
  • [45] PROTON PUMP INHIBITORS AND THE RISK FOR HOSPITAL-ACQUIRED CLOSTRIDIUM DIFFICILE IN ICU PATIENTS
    Barletta, Jeffrey
    Sclar, David
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [46] Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients
    Huang, Chien-Huei
    Tseng, Yung-Hsin
    Tsai, Wen-Shan
    Su, Chien-Chou
    Cheng, Ching-Lan
    Yang, Yea-Huei Kao
    Chang, Yu-Ching
    Liu, Yi-Hsuan
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (02) : 373 - 383
  • [47] Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients
    Chien-Huei Huang
    Yung-Hsin Tseng
    Wen-Shan Tsai
    Chien-Chou Su
    Ching-Lan Cheng
    Yea-Huei Kao Yang
    Yu-Ching Chang
    Yi-Hsuan Liu
    Infectious Diseases and Therapy, 2024, 13 : 373 - 383
  • [48] Re: Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients
    Abdalla, Jason
    Hassan, Tuyyab
    Kyprianou, Annette
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (04): : 601 - 602
  • [49] The Magnitude and Duration of Clostridium difficile Infection Risk Associated with Antibiotic Therapy: A Hospital Cohort Study
    Brown, Kevin A.
    Fisman, David N.
    Moineddin, Rahim
    Daneman, Nick
    PLOS ONE, 2014, 9 (08):
  • [50] Review: Proton-pump inhibitors are associated with increased risk for Clostridium difficile infection
    Koretz, Ronald L.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (04)
12345